B. Grygiel-Górniak
Molecular Biology · 2014
A researcher in the Science corpus: 1 paper; trusts 2 researchers and is trusted by 0 researchers here, as inferred from the citation graph.
Subfields
- Molecular Biology — 8 citations into it
- Endocrinology, Diabetes and Metabolism — 6 citations into it
Whom B. Grygiel-Górniak trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
Papers from B. Grygiel-Górniak's perspective
Ordered by how strongly the researchers B. Grygiel-Górniak trusts endorse each paper. Same corpus, a different order for every researcher.
- The mechanisms of action of PPARs. (Annual Review of Medicine)
- The PPARs: from orphan receptors to drug discovery. (Journal of Medicinal Chemistry)
- Peroxisome-proliferator-activated receptors and cancers: complex stories (Nature Reviews. Cancer)
- Effect of rosiglitazone on the risk of myocardial infarction and death from cardiovascular causes. (New England Journal of Medicine)
- Histopathology of pediatric nonalcoholic fatty liver disease (Hepatology)
- Fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease. (Circulation)
- Peroxisome Proliferator-activated Receptor α Activators Improve Insulin Sensitivity and Reduce Adiposity* (Journal of Biological Chemistry)
- Therapeutic roles of peroxisome proliferator-activated receptor agonists. (Diabetes)
- Molecular recognition of fatty acids by peroxisome proliferator-activated receptors. (Molecules and Cells)
- Diabetes, plasma insulin, and cardiovascular disease: subgroup analysis from the Department of Veterans Affairs high-density lipoprotein intervention trial (VA-HIT). (Archives of Internal Medicine)